The recent insider stock sale and lack of purchases over the last year raises caution. Despite SpartanNash's profitability and growth, the history of sales makes the situation cautious. The company is not eager to buy.
Market caution due to lack of EPS growth. If data indicates sustainable growth, the current sell-off could be an opportunity. However, risks and 1 warning sign for SpartanNash exist.
Despite minor downgrade in earnings per share forecasts, analysts don't foresee it leading to lower stock prices soon. They predict a slowdown in SpartanNash's revenue growth compared to industry peers.
I don't mean stock up on canned food for the apocalypse but honestly probably not a bad idea. What I mean is to invest in companies that manufacture and/or sell food. This isn't shit that get affected by consumer spending habits. Believe it or not, people still need to eat no matter how expensive it is. Looking at the blood bath of my portfolio today there are 3 that resisted:$Tyson Foods (TSN.US)$,$PepsiCo (PEP.US)$, and$SpartanNash (SPTN.US)$. As a side note ...
4
1
Report
ElonBust
:
Lol it’s been good during this dip but only if you already had it. Rn it’s KR’s turn to dip bc of that baby formula shortage, probably bounce back next week tho.
SpartanNash Stock Forum
In reaction to earnings/guidance:
• $Wolfspeed (WOLF.US)$ +22.2%, $Canadian Solar (CSIQ.US)$ +6.5%, $BJ's Wholesale Club Holdings (BJ.US)$ +5.8%, $Cisco (CSCO.US)$ +5.3%, $Keysight Technologies (KEYS.US)$ +4.3%, $Madison Square Garden Sports (MSGS.US)$ +3%, $NetEase (NTES.US)$ +2.7%, $NICE Ltd (NICE.US)$ +2.1%, $Synopsys (SNPS.US)$ + 1.8%
News:
• $Brooge Energy (BROG.US)$ +17.1% (says majority shareholder, BPGIC Holdings, would like to take ...
• $MorphoSys (MOR.US)$ +7.9% (entered into equity participation and license agreements for felzartamab and MOR210)
• $Day One Biopharmaceuticals (DAWN.US)$ +7.4% (prices offering of 10 mln shares of common stock at $15.00 per share)
• $Hertz Global (HTZ.US)$ +6.1% (authorizes new $2.0 bln share repurchase program)
• $EverCommerce (EVCM.US)$ +3.6% (announces $50 million share repurchase program)
• $Sprinklr (CXM.US)$ +3.6% (In ...
• $Repare Therapeutics (RPTX.US)$ +26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib)
• $Chewy (CHWY.US)$+19.8% (Chewy stock soars on earnings. Here's what really mattered)
• $UiPath (PATH.US)$ +11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million)
• $Pure Storage (PSTG.US)$ +10.6% (In reaction to earnings)
• $Credo Technology (CRDO.US)$ +10.2% (In reaction ...
What I mean is to invest in companies that manufacture and/or sell food. This isn't shit that get affected by consumer spending habits. Believe it or not, people still need to eat no matter how expensive it is.
Looking at the blood bath of my portfolio today there are 3 that resisted: $Tyson Foods (TSN.US)$ , $PepsiCo (PEP.US)$ , and $SpartanNash (SPTN.US)$. As a side note ...
• $Air Products & Chemicals (APD.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $275
• $Associated Banc (ASB.US)$: Wells Fargo Upgrades to Overweight from Equal Weight - PT $28 (from $26)
• $Armstrong World Industries (AWI.US)$: Jefferies Upgrades to Buy from Hold - PT $111 (from $101)
• $BlackBerry (BB.US)$: RBC Capital Upgrades to Sector Perform from Underperform - PT $7
• $Commerce Bancshares (CBSH.US)$: Wells Fargo Upgrades to Equal Weight from...
• $ACADIA Pharmaceuticals (ACAD.US)$: Canaccord Genuity Upgrades to Buy from Hold - PT $31 (from $30)
• $Host Hotels & Resorts (HST.US)$: Raymond James Upgrades to Outperform from Market Perform - PT $21
• $Magna International (MGA.US)$: Raymond James Upgrades to Market Perform from Underperform - PT $68
• $Micron Technology (MU.US)$: Bernstein Upgrades to Outperform from Market Perform - PT $94 (from $58)
• $Ultragenyx Pharmaceutical (RARE.US)$: Credit Sui...
No comment yet